C. Aceijas, G. V. Stimson, M. Hickman, and T. Rhodes, Global overview of injecting drug use and HIV infection among injecting drug users, AIDS, vol.18, issue.17, pp.2295-2303, 2004.
DOI : 10.1097/00002030-200411190-00010

A. Cohort-collaboration, HIV treatment response and prognosis in Europe and North America in the first decade of highly active antiretroviral therapy: a collaborative analysis, Lancet, vol.368, pp.451-458, 2006.

A. Ball, M. Beg, A. Doupe, and G. Weiler, Evidence for Action: A critical tool for guiding policies and programmes for HIV prevention, treatment and care among injecting drug users, International Journal of Drug Policy, vol.16, pp.1-6, 2005.
DOI : 10.1016/j.drugpo.2005.08.003

M. Bonacini, S. Louie, N. Bzowej, and A. Wohl, Survival in patients with HIV infection and viral hepatitis Bor C: a cohort study, AIDS, vol.18, pp.2081-2085, 2004.

A. Bouhnik, M. Preau, E. Vincent, M. Carrieri, H. Gallais et al., Depression and clinical progression in HIV-infected drug users treated with highly active antiretroviral therapy, Antiviral Therapy, vol.10, pp.53-61, 2000.

R. Bruce, F. Altice, M. Gourevitch, and G. Friedland, Pharmacokinetic Drug Interactions Between Opioid Agonist Therapy and Antiretroviral Medications, JAIDS Journal of Acquired Immune Deficiency Syndromes, vol.41, issue.5, pp.563-572, 2006.
DOI : 10.1097/01.qai.0000219769.89679.ec

J. Rehm, U. Frick, C. Hartwig, F. Gutzwiller, P. Gswend et al., Mortality in heroin-assisted treatment in Switzerland 1994???2000, Drug and Alcohol Dependence, vol.79, issue.2, pp.137-143, 1994.
DOI : 10.1016/j.drugalcdep.2005.01.005

T. Rhodes, G. Stimson, N. Crofts, A. Ball, K. Dehne et al., Drug injecting, rapid HIV spread and the " risk environment, AIDS, vol.13, pp.259-269, 1999.

T. Rhodes, C. Lowndes, A. Judd, L. A. Mikhailova, A. Sarang et al., Explosive spread and high prevalence of HIV infection among injecting drug users in, pp.25-31, 2002.

M. Rodriguez-artenas, I. Jarrin, J. Del-amo, J. Irribarren, S. Moreno et al., Delay in the initiation of HAART, poorer virological response, and higher mortality among HIV-infected injecting drug users in Spain, AIDS Research and Human Retroviruses, vol.228, pp.715-723, 2006.

C. Sabin, C. Smith, M. Youle, F. Lampe, D. Bell et al., Deaths in the era of HAART: contribution of late presentation, treatment exposure, resistance and abnormal laboratory markers, AIDS, vol.20, issue.1, pp.67-71, 2005.
DOI : 10.1097/01.aids.0000196178.73174.24

D. Salmon-ceron, C. Lewden, P. Morlat, S. Bevilacqua, E. Jougla et al., Liver disease as a major cause of death among HIV infected patients: role of hepatitis C and B viruses and alcohol, Journal of Hepatology, vol.42, issue.6, pp.799-805
DOI : 10.1016/j.jhep.2005.01.022

J. Egger, M. Swiss, and H. Study, Long-term effectiveness of potent antiretroviral therapy in preventing AIDS and death: a prospective cohort study. The Lancet, pp.378-384, 2005.

M. Sulkowski, R. Moore, S. Mehta, R. Chaisson, and D. Thomas, Hepatitis C and Progression of HIV Disease, JAMA, vol.288, issue.2, pp.241-244, 2002.
DOI : 10.1001/jama.288.2.199

P. Sullivan, D. Hanson, E. Teshale, L. Wotring, and J. Brooks, Effect of hepatitis C infection on progression of HIV disease and early response to initial antiretroviral therapy, AIDS, vol.20, issue.8, pp.1171-1180, 2006.
DOI : 10.1097/01.aids.0000226958.87471.48

F. Termorshuizen, A. Krol, M. Prins, and E. Van-ameijden, Long-term Outcome of Chronic Drug Use: The Amsterdam Cohort Study among Drug Users, American Journal of Epidemiology, vol.161, issue.3, pp.271-279, 2005.
DOI : 10.1093/aje/kwi035

L. Thorpe, M. Frederick, J. Pitt, I. Cheng, D. Watts et al., Effect of Hard-Drug Use on CD4 Cell Percentage, HIV RNA Level, and Progression to AIDS-Defining Class C Events Among HIV-Infected Women, JAIDS Journal of Acquired Immune Deficiency Syndromes, vol.37, issue.3, pp.1423-1430, 2004.
DOI : 10.1097/01.qai.0000127354.78706.5d

. Un-millennium and . Project, Combating AIDS in the developing world. Task force on HIV/AIDS, Malaria, TB and access to essential Medicines, 2005.

L. Van-asten, R. Zangerle, I. Hernandez-aguado, F. Boufassa, B. Broers et al., Do HIV Disease Progression and HAART Response Vary among Injecting Drug Users in Europe?, European Journal of Epidemiology, vol.13, issue.9, pp.795-804, 2005.
DOI : 10.1007/s10654-005-1049-0

L. Wiessing and A. Nardone, Ongoing HIV and viral hepatitis infections in IDUs across the EU, 2001.

A. Wodak and A. Cooney, Effectiveness of sterile needle and syringe programmes, International Journal of Drug Policy, vol.16, pp.31-44, 2005.
DOI : 10.1016/j.drugpo.2005.02.004

E. Wood, R. Hogg, T. Kerr, A. Palepu, R. Zhang et al., Impact of accessing methadone on the time to initiating HIV treatment among antiretroviral-naive HIV-infected injection drug users, AIDS, vol.19, issue.8, pp.837-839, 2005.
DOI : 10.1097/01.aids.0000168982.20456.eb